Compounds according to {HEAD ~ the invention bind} to and are {TAIL ~ agonists}, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation 
to
Compounds according to { HEAD ~ the invention bind } to and are { TAIL ~ agonists } , antagonists or inverse agonists of the CB2 receptor , and are useful for treating inflammation
OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH